Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Japan Technology Journal.
Press releases published on September 29, 2025

Cryogenic Valve Assembly Market to Reach USD $6.76 Billion by 2029 at 8.4% CAGR
The Business Research Company's Cryogenic Valve Assembly Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 29, 2025 /EINPresswire.com/ -- What Is The Estimated Industry Size …

Digital Twin Urban Lighting Network Market is Forecasted to Reach a Value of US $5.82 Billion by 2029
The Business Research Company’s Digital Twin Urban Lighting Network Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 27, 2025 /EINPresswire.com/ -- Get 30% Off All Global …

Drone-Assisted Roof Hail Damage Scan Market Anticipated to Grow at 20% CAGR Through 2029: Industry Report
The Business Research Company’s Drone-Assisted Roof Hail Damage Scan Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 29, 2025 /EINPresswire.com/ -- How Big Is The Drone-Assisted …

Digital Twin Urban Rail Signal Market to Reach $3.5 Billion by 2029 | The Business Research Company
The Business Research Company’s Digital Twin Urban Rail Signal Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 27, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market …

Drone-Assisted Urban Light Detection And Ranging (LiDAR) Mapping Market Trends and Analysis by Application, Vertical
TBRC’s Drone-Assisted Urban Light Detection And Ranging (LiDAR) Mapping Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 29, 2025 /EINPresswire.com/ -- What Is The Estimated …


Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)
– KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated and full approval – – KOMET-017-NIC trial of venetoclax / azacitidine combination will assess CR …